{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:42Z","timestamp":1791835842601,"version":"4.3.4"},"reference-count":50,"publisher":"Portland Press Ltd.","issue":"16","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"funder":[{"name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","award":["82270368"],"award-info":[{"award-number":["82270368"]}]},{"name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","award":["81873523"],"award-info":[{"award-number":["81873523"]}]},{"name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","award":["82070490"],"award-info":[{"award-number":["82070490"]}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Diabetic cardiomyopathy (DCM) is a chronic metabolic disease with few effective therapeutic options. Immunoproteasome is an inducible proteasome that plays an important role in the regulation of many cardiovascular diseases, while its role in DCM remains under discussion. The present study aims to demonstrate whether inhibiting immunoproteasome subunit low molecular weight polypeptide 7 (LMP7) could alleviate DCM. Here, we established a type I diabetes mellitus mouse model by streptozotocin (STZ) in 8-week-old male wild-type C57BL\/6J mice. We found that immunoproteasome subunit LMP7 was overexpressed in the heart of diabetic mice, while inhibiting LMP7 with pharmacological inhibitor ONX0914 significantly alleviated myocardial fibrosis and improved cardiac function. Besides, compared with diabetic mice, ONX0914 treatment reduced protein levels of mesenchymal markers (Vimentin, \u03b1-smooth muscle actin, and SM22\u03b1) and increased endothelial markers (VE-cadherin and CD31). In TGF\u03b21 stimulated HUVECs, we also observed that ONX0914 could inhibit endothelial\u2013mesenchymal transition (EndMT). Mechanistically, we prove that ONX0914 could regulate autophagy activity both in vivo and vitro. Meanwhile, the protective effect of ONX0914 on TGF\u03b21 stimulated HUVECs could be abolished by 3-methyladenine (3MA) or hydroxychloroquine (CQ). All in all, our data highlight that inhibition of LMP7 with ONX0914 could ameliorate EndMT in diabetic mouse hearts at least in part via autophagy activation. Thus, LMP7 may be a potential therapeutic target for the DCM.<\/jats:p>","DOI":"10.1042\/cs20230732","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T08:46:08Z","timestamp":1691484368000},"page":"1297-1309","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ONX0914 inhibition of immunoproteasome subunit LMP7 ameliorates diabetic cardiomyopathy <i>via<\/i> restraining endothelial\u2013mesenchymal transition"],"prefix":"10.1042","volume":"137","author":[{"given":"Mengwen","family":"Wang","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujian","family":"Liu","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhong","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5160-4427","authenticated-orcid":false,"given":"Hesong","family":"Zeng","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China"},{"name":"2Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan 430030, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"2023082210110424500_B1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2019","edition":"9th edn"},{"key":"2023082210110424500_B2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy - a comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"key":"2023082210110424500_B3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"2023082210110424500_B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","article-title":"Of mice and men: models and mechanisms of diabetic cardiomyopathy","volume":"114","author":"Riehle","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"2023082210110424500_B5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"2023082210110424500_B6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"2023082210110424500_B7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"2023082210110424500_B8","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","article-title":"The ubiquitin-proteasome pathway: on protein death and cell life","volume":"17","author":"Ciechanover","year":"1998","journal-title":"EMBO J."},{"key":"2023082210110424500_B9","doi-asserted-by":"publisher","first-page":"10976","DOI":"10.1073\/pnas.96.20.10976","article-title":"The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study","volume":"96","author":"Groll","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023082210110424500_B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/jem.187.1.97","article-title":"Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits","volume":"187","author":"Griffin","year":"1998","journal-title":"J. Exp. Med."},{"key":"2023082210110424500_B11","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.2741\/4027","article-title":"Immune and non-immune functions of the immunoproteasome","volume":"17","author":"Angeles","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"2023082210110424500_B12","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00018-012-0938-0","article-title":"Emerging roles of immunoproteasomes beyond MHC class I antigen processing","volume":"69","author":"Ebstein","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"2023082210110424500_B13","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1172\/JCI92335","article-title":"A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide\/HLA-I antigens","volume":"127","author":"Chang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"2023082210110424500_B14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4143\/crt.2017.500","article-title":"Expression of immunoproteasome subunit LMP7 in breast cancer and its association with immune-related markers","volume":"51","author":"Lee","year":"2019","journal-title":"Cancer Res. Treat."},{"key":"2023082210110424500_B15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"key":"2023082210110424500_B16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.yjmcc.2019.09.010","article-title":"Genetic ablation and pharmacological inhibition of immunosubunit beta5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice","volume":"137","author":"Cao","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"2023082210110424500_B17","doi-asserted-by":"publisher","first-page":"eaau0495","DOI":"10.1126\/sciadv.aau0495","article-title":"The immunoproteasome catalytic \u03b25i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation","volume":"5","author":"Xie","year":"2019","journal-title":"Sci. Adv."},{"key":"2023082210110424500_B18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.yjmcc.2010.02.007","article-title":"Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice","volume":"49","author":"Zu","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"2023082210110424500_B19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.24205\/03276716.2020.4021","article-title":"Inhibition of low-molecular mass protein-7 alleviates hyperglycemia-induced myocardial apoptosis by repairing metabolism disorder and inflammation","volume":"2","author":"Shui","year":"2021","journal-title":"Revista Argentina De Cl\u00ednica Psicol\u00f3gica."},{"key":"2023082210110424500_B20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"2023082210110424500_B21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"2023082210110424500_B22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ. Res."},{"key":"2023082210110424500_B23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","article-title":"Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies","volume":"173","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2023082210110424500_B24","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","article-title":"Endothelial-mesenchymal transition in cardiovascular disease","volume":"41","author":"Alvandi","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2023082210110424500_B25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1475-2840-4-12","article-title":"Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor","volume":"4","author":"Han","year":"2005","journal-title":"Cardiovasc Diabetol."},{"key":"2023082210110424500_B26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvx253","article-title":"Endothelial-mesenchymal transition in atherosclerosis","volume":"114","author":"Souilhol","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"2023082210110424500_B27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/15548627.2017.1414755","article-title":"Engagement of circular RNA HECW2 in the nonautophagic role of ATG5 implicated in the endothelial-mesenchymal transition","volume":"14","author":"Yang","year":"2018","journal-title":"Autophagy"},{"key":"2023082210110424500_B28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41419-018-1098-4","article-title":"Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits \u03b25i","volume":"9","author":"Yin","year":"2018","journal-title":"Cell Death Dis."},{"key":"2023082210110424500_B29","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.7150\/ijbs.60459","article-title":"The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"2023082210110424500_B30","doi-asserted-by":"publisher","first-page":"758158","DOI":"10.3389\/fcvm.2021.758158","article-title":"Activated protein C ameliorates diabetic cardiomyopathy via modulating OTUB1\/YB-1\/MEF2B Axis","volume":"8","author":"Zhong","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"2023082210110424500_B31","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.jbc.2022.101989","article-title":"ERK\/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1","volume":"298","author":"Zhong","year":"2022","journal-title":"J. Biol. Chem."},{"key":"2023082210110424500_B32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/ATVBAHA.111.234286","article-title":"Transforming growth factor-\u03b2-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21","volume":"32","author":"Kumarswamy","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2023082210110424500_B33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"2023082210110424500_B34","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.redox.2020.101600","article-title":"Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy","volume":"36","author":"Kong","year":"2020","journal-title":"Redox. Biol."},{"key":"2023082210110424500_B35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"2023082210110424500_B36","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"2023082210110424500_B37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.freeradbiomed.2005.10.052","article-title":"Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells","volume":"40","author":"Kotamraju","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"2023082210110424500_B38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2016.03.026","article-title":"Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR\/JAK1\/STAT3 signaling","volume":"29","author":"Zhang","year":"2016","journal-title":"Cancer Cell."},{"key":"2023082210110424500_B39","doi-asserted-by":"publisher","first-page":"F548","DOI":"10.1152\/ajprenal.00509.2020","article-title":"Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes","volume":"320","author":"Lee","year":"2021","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"2023082210110424500_B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2016.06.004","article-title":"miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy","volume":"433","author":"Sun","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"2023082210110424500_B41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.yjmcc.2019.09.010","article-title":"Genetic ablation and pharmacological inhibition of immunosubunit \u03b25i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice","volume":"137","author":"Cao","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"2023082210110424500_B42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/HYPERTENSIONAHA.118.11813","article-title":"Immunoproteasome subunit \u03b25i promotes Ang II (Angiotensin II)-induced atrial fibrillation by targeting ATRAP (Ang II Type I receptor-associated protein) degradation in mice","volume":"73","author":"Li","year":"2019","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"2023082210110424500_B43","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41419-018-1098-4","article-title":"Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits beta5i","volume":"9","author":"Yin","year":"2018","journal-title":"Cell Death Dis."},{"key":"2023082210110424500_B44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.2337\/db15-1033","article-title":"miR-200b mediates endothelial-to-mesenchymal transition in diabetic cardiomyopathy","volume":"65","author":"Feng","year":"2016","journal-title":"Diabetes"},{"key":"2023082210110424500_B45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"key":"2023082210110424500_B46","doi-asserted-by":"publisher","first-page":"e30450","DOI":"10.1371\/journal.pone.0030450","article-title":"Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice","volume":"7","author":"Eguchi","year":"2012","journal-title":"PLoS ONE"},{"key":"2023082210110424500_B47","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/15548627.2015.1051295","article-title":"Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes","volume":"11","author":"Kanamori","year":"2015","journal-title":"Autophagy"},{"key":"2023082210110424500_B48","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2337\/db10-0351","article-title":"Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice","volume":"60","author":"Xie","year":"2011","journal-title":"Diabetes"},{"key":"2023082210110424500_B49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","article-title":"Cardiac fibrosis: new insights into the pathogenesis","volume":"14","author":"Ma","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"2023082210110424500_B50","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbrc.2017.04.130","article-title":"Autophagy regulates endothelial-mesenchymal transition by decreasing the phosphorylation level of Smad3","volume":"487","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/137\/16\/1297\/949110\/cs-2023-0732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/137\/16\/1297\/949110\/cs-2023-0732.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T10:11:50Z","timestamp":1692699110000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/137\/16\/1297\/233354\/ONX0914-inhibition-of-immunoproteasome-subunit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20230732","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,8]]}}}